NBCA to Attend International Society on Thrombosis and Haemostasis Conference (ISTH) 2022

NBCA to Attend International Society on Thrombosis and Haemostasis Conference (ISTH) 2022

July 9, 2022 – July 13, 2022

NBCA will be attending ISTH 2022, where thousands of the world’s leading experts on thrombosis and hemostasis will come together and present advances in the field, exchange the latest science, and discuss new clinical applications. There will be an extensive lineup of educational sessions, poster presentations, lectures, booth exhibits, and networking opportunities all aiming to advance patient care.

Members from NBCA’s Medical and Scientific Advisory Board (MASAB) and key stakeholders in NBCA will be presenting NBCA related abstracts at this conference. NBCA will also have an exhibit booth where members can learn more about NBCA, and the life-saving information we have to offer to patients.

NBCA Related Abstracts

  • The Clues Study: A Critical Look at Understanding the Emotional Suffering of Blood Clot Survivors 
    • Educational Session: Sunday, July 10, 6:30 PM (GMT+1) 
    • “Important aspects of post-venous thromboembolic (VTE) syndrome are dyspnea, pain, anxiety, depression and post-traumatic stress disorder (PTSD). The correlations between all of these features and their impact on functional outcomes and quality of life (QOL) are not well studied and thus poorly understood.”
  • Using Natural Language Processing to Diagnose Venous Thromboembolism
    • Educational Session: Tuesday, July 12, 6:30 PM (GMT+1) 
    • “Venous thromboembolism (VTE) is the leading cause of preventable in-hospital mortality, and identifying these events is a core metric of hospital quality measures. Understanding the current incidence of VTE can be challenging because organizations often rely on humans to review charts and diagnoses codes. Natural language processing (NLP) offers a promising alternative, allowing for rapid extraction of relevant data from extensive medical records.”
  • Patients Reporting on Relevant Functional Limitations Following an Episode of Venous Thromboembolism
    • Educational Session: Sunday July 10, 6:30 PM (GMT+1) 
    • “Beyond recurrent venous thromboembolism (VTE), major bleeding and death, quality of life (QOL) and functional ability are highly relevant clinical outcomes of VTE survivors. However, these features and other important determinants of well-being have not been well explored.”
  • Patients Reporting of Post-Traumatic Stress Disorder After Experiencing Venous Thromboembolic Event
    • Educational Session: Sunday July 10, 6:30 PM (GMT+1) 
    • “The main focus of care for patients with venous thromboembolism (VTE) is to prevent recurrent VTE, major bleeding and death. While these are highly relevant, they do not capture patient-relevant outcomes such as quality of life (QOL) and functional abilities.”
  • Artificial Intelligence in the Prediction of Venous Thromboembolism
    • Educational Session: Tuesday, July 12, 3:45 PM (GMT+1)
      • NBCA President, Leslie Lake, is a co-author of this abstract
    • “Accurate diagnostic and prognostic predictions of venous thromboembolism (VTE) are crucial for VTE management. Artificial intelligence (AI) enables autonomous identification of the most predictive patterns from large complex data. Evidence regarding its performance in VTE prediction are emerging. Systematic reviews of current evidence are lacking.”

NBCA Materials Being Showcased

Questions? Email Julia Thompson: jthompson@stoptheclot.org

Current News

The National Blood Clot Alliance Launches New Council for Emerging Researchers in Thrombosis (CERT)

FOR IMMEDIATE RELEASE: 07/28/2022   The National Blood Clot Alliance (NBCA), the nation’s leading nonprofit patient advocacy organization dedicated to…

The FUVID Study

The FUVID Study (Functional Characterization of Chronic Thromboembolic Venous Disease in Children) is currently open for enrollment to qualified participants.…